LinkDoc Technology Inc, a healthcare technology company, has filed Form F-1 Registration Statement on June 14, 2021 with the U.S. Securities and Exchange Commission to raise up to $100 million IPO. Pricing terms are yet to announce.
The company a leading data-driven and AI-enabled healthcare technology company in terms of first mover in cultivating high-quality medical data assets with the largest set of China oncology cohorts, according to Frost & Sullivan.
The Beijing, China-based company was founded in 2014 and booked $157 million in sales for the 12 months ended March 31, 2021. It plans to list on the Nasdaq Global Select Market under the symbol “LDOC.” Morgan Stanley, BofA Securities, and CICC are underwriters of the IPO.
The company engages Davis Polk & Wardwell LLP as US Securities Counsel, and KPMG Huazhen LLP as Independent Auditor.
#ipo #nasdaq #LinkDoc #healthcare #technology #LDOC
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected]